ArticleTransplantation and cellular therapy2026
CRS or ICANS Are Rare Beyond 2 Weeks After Lisocabtagene Maraleucel Infusion: Data From Clinical Trials and the Real-World Setting.
Bradley D Hunter et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.